Family Medicine Doctors in Denton, NC Accepting Medicare
1 Family Medicine doctors found. Showing 1 - 1
 Dr. Felizardo Hocbo Mangundayao, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 292 South Main St., Denton, NC 27239 Phone: 336-859-2121 Fax: 336-859-2122 |
News Archive
Stem cell-enriched autologous fat treatment safe for breast reconstruction after cancer surgery
Since 2003, breast augmentation utilizing stem cells from autologous fat has been developed enabling silicon-free breast reconstruction following cancer surgery. Till now though, it was unclear whether this might reactivate the cancer again. However, University of Pittsburgh researchers led by Prof. Albert Donnenberg have now demonstrated that stem cell-enriched autologous fat is safe even in the presence of inactive tumor cells.
Rural hospitals: Does the health law help or hurt?
Some politicians and hospital administrators worry that the new health law will cause rural facilities to lose revenue, bucking the trend of Washington's political establishment's long support for rural hospitals, the Omaha World-Herald reports. The law does have "pro-rural provisions" that received bipartisan support. But as the federal government writes rules for the law, partisan interpretations of the true impact on rural hospitals has continued.
Primary sclerosing cholangitis: Therapy with synthetic bile acid acts directly on the immune system
Primary Sclerosing Cholangitis (PSC) is a rare, chronic inflammatory disease of the bile ducts and is difficult to treat. Studies conducted by the Division of Gastroenterology and Hepatology at MedUni Wien under the guidance of Michael Trauner (Department of Internal Medicine III) were able to show positive effects from the administration of synthetically produced bile acids and bile acid receptor agonists.
Regulatory T cells learn what to protect while in the thymus and that everything the cells learn may not be good
Regulatory T cells, which function like immune system police, learn early in life what to protect, and that may include viruses, bacteria and tumors, researchers have shown.
Intralytix awarded U.S. patent for bacteriophage treatment of colonization by pathogenic bacteria
Intralytix, Inc., announced today that it has been issued a patent by the U.S. Patent & Trademark Office covering the use of bacteriophages to reduce the risk of bacterial infection in persons colonized with pathogenic bacteria including MRSA.
› Verified 5 days ago